Exelixis EXEL Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's net change in cash?
- Exelixis (EXEL) reported net change in cash of -$256.34M in Q1 2026.
- How has Exelixis's net change in cash changed year-over-year?
- Exelixis's net change in cash decreased by 662.4% year-over-year, from -$33.62M to -$256.34M.
- What is the long-term trend for Exelixis's net change in cash?
- Over 3 years (2021 to 2025), Exelixis's net change in cash has grown at a -8.2% compound annual growth rate (CAGR), from $343.12M to $265.11M.
- What does net change in cash mean?
- The total change in the company's cash balance over the period.
- How do you interpret net change in cash?
- An increase indicates positive net cash flow, while a decrease suggests cash burn or significant capital deployment.
- How does net change in cash compare across companies?
- Standard across all public companies; peers in biotech often show high volatility due to R&D cycles.